Recent Blog Articles

Harvard Health Blog

Is IBD an underrecognized health problem in minority groups?

GettyImages-674585000
May 07, 2021

Disclaimer:

As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

Comments

azure
May 07, 2021

How many people of color, male and female, are included in new drug trials? Particularly the biologics, which seem to be the medication of choice/most prescribed by gastroenterologists for Crohn’s disease? I have a close relative who developed Crohn’s at 16 years, she was careful regarding diet, medication compliance (this is pre-biologics) and yet she still developed at least one fistulas. Ultimately, she had surgery (colostomy), so according to her surgeon, she no longer has Crohn’s, although it’s always possible for the inflammation to resurface elsewhere in her body. In addition, at least some of the biologics seem to have severe long term side effects, although often they seem to provide the best symptom control–while they work.

Commenting has been closed for this post.

You might also be interested in…

Harvard Health Letter

Want to reduce pain in your knees and be more active? Eat smarter and reduce your risk for a heart attack? Improve your flexibility and balance so you don’t fall? Sleep the entire night so you have more energy during the day? Take control of your health right now! In Harvard Health Letter, you’ll find easy remedies and solutions to these common challenges and more.

Read More